Patents Examined by Kortney L Klinkel
  • Patent number: 10689534
    Abstract: The present invention provides an aqueous dry-erasable ink or marking composition, which could be applied to both porous and non-porous surfaces and erasable from both porous and non-porous surfaces or marking substrates. The present invention further provides erasure of mark made by the ink composition from such porous and non-porous substrate, which is achieved by a cloth or the like, without requiring rubbing by conventional erasers. The ink composition comprises water, composite pigment, one or more rheology additive, one or more wetting agent, one or more water-soluble resin, pH adjuster and one or more biocide. The composite pigment is a compound of polymer resin and colored pigment at a weight ratio from 10/90 to 97/3.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: June 23, 2020
    Inventor: Ali Fallahassady
  • Patent number: 10653608
    Abstract: The invention relates to a cosmetic product, comprising a) a cosmetic preparation, containing, in relation to its total weight, a1) about 45 to about 98 wt. % of at least one polar solvent; a2) about 0.5 to about 15 wt. % of at least one copolymer from the monomers i) n-tert-octylacrylamide, ii) acrylic acid, iii) tert-butylamino ethyl methacrylate, iv) and optionally other monomers; b) a device for flash evaporation of the cosmetic preparation a), and to a method using corresponding products and to the use of the cosmetic preparation a) as process material in a device for flash evaporation.
    Type: Grant
    Filed: November 2, 2015
    Date of Patent: May 19, 2020
    Assignee: Henkel AG & Co. KGaA
    Inventors: Thomas Foerster, Rolf Bayersdoerfer, Thorsten Knappe
  • Patent number: 10653589
    Abstract: Disclosed is a personal care composition comprising boron nitride in combination with a non-silicone polyolefin particle in a cosmetically acceptable carrier to provide benefits of enhanced skin appearance.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: May 19, 2020
    Assignee: Conopco, Inc.
    Inventors: Wenyan Dong, Naresh Dhirajlal Ghatlia, Lin Wang
  • Patent number: 10645929
    Abstract: Provided is a compound represented by formula (I), or an N-oxide thereof: wherein: A1 represents a nitrogen atom or a CR4; R4 represents a hydrogen atom or the like; R1 represents a C2-C10 chain hydrocarbon group having one or more halogen atoms or the like; R2 represents a C1-C6 alkyl group optionally having one or more halogen atoms or the like; q represents 0, 1, 2, or 3; R3 represents a C1-C6 chain hydrocarbon group optionally having one or more substituents selected from Group B or the like; p represents 0, 1, or 2; R6 represents a C1-C6 alkyl group optionally having one or more halogen atoms or the like; and n represents 0, 1, or 2. The compound of formula (I) has excellent control efficacies against harmful arthropods.
    Type: Grant
    Filed: October 26, 2016
    Date of Patent: May 12, 2020
    Inventors: Kohei Orimoto, Yoshihiko Nokura, Yuji Nakajima, Takamasa Tanabe
  • Patent number: 10632058
    Abstract: The invention relates to a copolymer resulting from the polymerization of: (i) 70% to 95% by weight, of the total weight of the monomers, of isobornyl (meth)acrylate; (ii) 1% to 30% by weight of vinylphosphonic acid monomer; (iii) 0 to 20% by weight of an additional monomer. The invention also relates to a cosmetic composition comprising the copolymer and to a cosmetic process for caring for or making up keratin materials, comprising the topical application of the composition to the keratin materials. It also relates to the use of the copolymer as a skin-tensioning agent.
    Type: Grant
    Filed: June 25, 2015
    Date of Patent: April 28, 2020
    Assignee: L'OREAL
    Inventors: Bertrand Lion, Laurent Sabatie
  • Patent number: 10590110
    Abstract: Deuterated domperidone compositions, methods of synthesis, methods of use, and dosing formulations providing beneficial safety and other effects.
    Type: Grant
    Filed: April 16, 2019
    Date of Patent: March 17, 2020
    Assignee: CinDome Pharma, LLC
    Inventors: Catherine Pearce, Jon Isaacsohn, Piyush Patel
  • Patent number: 10568840
    Abstract: A self-assembled gel composition with enhanced adhesion to cartilage tissue is provided. A cationic agent co-self assembles with a generally regarded as safe (GRAS), low molecular weight (<2,500 Da) gelator, forming homogeneous self-supporting gel that can encapsulate one or more therapeutic agents for controlled release. The composition adheres to connective tissue, e.g., cartilage, to a greater extent and a greater length of time than a self-assembled gel from gelators alone. The composition is used to specifically target connective tissue and deliver one or more therapeutic, prophylactic, or diagnostic agents for controlled release to improve dosing efficacy.
    Type: Grant
    Filed: May 8, 2017
    Date of Patent: February 25, 2020
    Assignee: The Brigham and Women's Hospital, Inc.
    Inventors: Jeffrey Karp, Nitin Joshi, Xueyin He, Sachin Bhagchandani
  • Patent number: 10561630
    Abstract: A capsule oral delivery system is disclosed. The system includes an outer capsule completely enclosing an inner content, or a hard shell comprised of hydroxypropyl methylcellulose (HPMC) enclosing the content. A liquid formulation forming the inner content of the outer capsule is comprised of a hydroxycitric acid (HCA) salt, water, and glycerol, with the HCA being completely dissolved in the water and glycerol which may be the only components present in the capsule, which may be administered to a patient in a method of treatment to cause weight loss when repeatedly administered.
    Type: Grant
    Filed: October 11, 2017
    Date of Patent: February 18, 2020
    Inventors: Dallas L. Clouatre, Daniel E. Clouatre
  • Patent number: 10548830
    Abstract: A transdermal formulation which can be applied to the skin, body, face using a combination of glutathione, in the presence of a wide range of active components while increasing permeation of active antioxidant agents. A therapeutically effective amount creates in the patient (i) regulation of sleep, (ii) increased energy during awake periods, (iii) improved concentration during awake periods, (iv) reduction of facial wrinkles, and (v) reduction of joint and muscular pain with increases by at least 10 percent of the ability of skin to retain moisture and totally absorb the glutathione without requiring injection or oral supplementation of the glutathione.
    Type: Grant
    Filed: June 6, 2019
    Date of Patent: February 4, 2020
    Inventor: Rachel Sarah Levine
  • Patent number: 10538631
    Abstract: The present invention relates to benefit agent containing delivery particles, compositions comprising said particles, and processes for making and using the aforementioned particles and compositions. When employed in compositions, for example, cleaning or fabric care compositions, such particles increase the efficiency of benefit agent delivery, thereby allowing reduced amounts of benefit agents to be employed. In addition to allowing the amount of benefit agent to be reduced, such particles allow a broad range of benefit agents to be employed.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: January 21, 2020
    Assignee: The Procter & Gamble Company
    Inventors: Yousef Georges Aouad, Johan Smets, Luke Andrew Zannoni, Piero Baglioni, Paolo Tempesti, Arianna Bartolini
  • Patent number: 10524475
    Abstract: The invention relates to selective herbicidal compositions that comprise an effective amount of an active compound combination comprising (a) one or more compounds of the formula (I) in which Q1, Q2, R1, R2, R3 and R4 are as defined in the disclosure—and salts of the compounds of the formula (I)— and (b) at least one of the crop-plant-compatibility-improving compounds listed in the disclosure. The invention further relates to the use of these compositions for controlling undesirable vegetation and to a process for preparing the compositions according to the invention.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: January 7, 2020
    Inventors: Dieter Feucht, Peter Dahmen, Mark Wilhelm Drewes, Rolf Pontzen, Ernst Rudolf F. Gesing, Hans-Georg Schwarz, Klaus-Helmur Mueller
  • Patent number: 10517838
    Abstract: The invention refers to novel compositions with at least one prehormone, hormone from group consisting of mevalonate derivatives or from the group consisting of peptides and/or proteohormones and at least one mineral, constituent by preference iodine, selen and at least one Ginkgoloide against alkyl-acyl-GPC (AAGPC), its derivatives (alkyllipids) and/or products (e.g. acetylacyl-CoA). These new hormonal compositions are manufactured with at least one Ginkgoloide and/or acetylcysteine for oral, dietary, oily or local, cosmetic administration. Novel cosmetic preparations without addition of ether/volatile oils contain Ginkgoloides with at least one sun screening agent against impairments of pigmentation. The novel compositions are manufactured with prehormones and constituents to protect against alkylacyl-like destabilization of cells by preference under the conditions of critical lifestyle, critical morning urine samples and/or hypersensitivity syndromes.
    Type: Grant
    Filed: December 21, 2006
    Date of Patent: December 31, 2019
    Inventor: Ruth-Maria Korth
  • Patent number: 10517304
    Abstract: A rodenticide composition is described along with a method for using the same to exterminate rodents. The composition features a mixture of a dehydrant, a composition for producing endogenous gas, a dietary emulsifier, a hypercalcemia promoter, and a source of cellulose. After consumption of the composition by a rodent, the dehydrant and source of cellulose cause the rodent to experience dehydration, while the endogenous gas produced by the composition causes bloating and increased digestive stress. The dietary emulsifier and hypercalcemia promoter cause digestive stress, which reduces the rodent's desire to feed and quickens dehydration and death. Once the rodenticide composition is prepared, it may be placed in areas frequented by or infested with rodents so as to kill the rodents once they consume the composition. One or more flavorings, coloring agents, and weather resistant materials may also be added to the composition.
    Type: Grant
    Filed: April 5, 2017
    Date of Patent: December 31, 2019
    Inventor: Stephen C. Perry
  • Patent number: 10500145
    Abstract: A temporary tattooing ink is produced from concentrated genipin. In one embodiment, the concentrated genipin forms part of a solution. In another embodiment, the genipin is provided in a gel form which also includes a solvent and a thickening agent. Finally, an applicator is described into which genipin may be embedded for applying to a user's skin.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: December 10, 2019
    Assignee: inkbox ink inc.
    Inventors: Tyler James Handley, Braden Handley, Christopher Blain Caputo, Adam Manuel Zrehen
  • Patent number: 10485873
    Abstract: Mikto-arm star polymers were prepared comprising non-charged hydrophilic poly(ethylene oxide) arms and hydrophobic arms comprising a poly(propylene oxide) chain or phytol group. The polymer arms are covalently linked to a hydrophobic crosslinked polyester core formed by ring opening polymerization of a bis-cyclic ester initiated by mono-nucleophilic polymer arm precursors. The mikto-arm star polymers show improved loading capacity for Coenzyme Q10 (CoQ10).
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: November 26, 2019
    Assignees: International Business Machines Corporation, NanoMalaysia Berhad
    Inventors: Khairiah H. Badri, Emilia B. A. Malek, Siti Mariam B. Mohd Nor, Victoria A. Piunova
  • Patent number: 10478403
    Abstract: A device for delivery of a therapeutic agent to a surgical cavity, including: a porous, mucoadhesive, freeze-dried polymeric matrix having first and second opposed surfaces, the matrix formed by a composition including chitosan; a plurality of particles embedded within the matrix, the particles containing the therapeutic agent and having a coating around the therapeutic agent, the coating including chitosan; and an additive selected from the group consisting of a hydration promoter, a particle adhesion inhibitor, a particle aggregation inhibitor, and combinations thereof. The first surface of the matrix is configured to be applied to the surgical cavity; the device releases the particles through the first surface; the device is also sterilized and provides release of approximately 20% to 100% of the therapeutic agent within 20 minutes of application to the surgical cavity.
    Type: Grant
    Filed: May 3, 2018
    Date of Patent: November 19, 2019
    Assignee: Privo Technologies, Inc.
    Inventors: Manijeh Nazari Goldberg, Brandon LaPorte, Aaron Manzi, Amani Jahjaa
  • Patent number: 10463691
    Abstract: The present invention discloses compositions and edible orally delivered products, such as candies, beverages, nutritional bars and dietary supplements that increase bone growth and treat age-related bone loss in humans. The major component of the invention is biological calcium which is derived from natural eggshell powder. The compositions also include organic honey and lemon.
    Type: Grant
    Filed: April 27, 2017
    Date of Patent: November 5, 2019
    Inventors: Jargalsaikhan Shagdar, Odonchimeg Myagmar
  • Patent number: 10457635
    Abstract: The present invention relates to a process for the preparation of the mono sodium salt of the derivative 3,5-diiodo-O-[3-iodo-4-(sulphooxy)phenyl]-L-tyrosine (T3S) by starting from the corresponding phenolic compound, in the presence of chlorosulfonic acid and dimethylacetamide as a solvent. The so obtained T3S compound may conveniently be isolated in a pure form as a solid in good yields. The present invention further relates to the process for T3S preparation, wherein the starting reagent is T2 and further comprising the formulation of such compound in tablets. Furthermore, the invention discloses non-radioactive immunoassays based on T3S derivatives.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: October 29, 2019
    Assignee: BRACCO IMAGING S.p.A.
    Inventors: Pier Lucio Anelli, Maria Argese, Valeria Boi, Livio Cavalieri, Laura Galimberti, Sonia Gazzetto, Luciano Lattuada, Federico Maisano, Giovanni Rivolta, Fulvia Vella
  • Patent number: 10449216
    Abstract: Disclosed are methods for modulating the activity of an orthosteric or allosteric drug on a group I metabotropic glutamate receptor (mGluR) by increasing or decreasing the levels of extracellular Ca2+.
    Type: Grant
    Filed: September 15, 2014
    Date of Patent: October 22, 2019
    Assignee: Georgia State University Research Foundation, Inc.
    Inventors: Jenny J. Yang, Jason Y. Jiang
  • Patent number: 10426727
    Abstract: The present invention provides therapeutic formulations, including therapeutic nanoemulsions, and related methods for the in vivo delivery of hydrophobic compounds, including an important class of hydrophobic anesthetics. Formulations and methods of the invention include semifluorinated block copolymers, and optionally phospholipid surfactants, capable of forming a stable nanoemulsion without the need of conventional lipid components that support bacterial and/or fungal growth (e.g., soybean oil and similar lipids). In certain embodiments, emulsion-based formulations are provided that are capable of formulating, delivering and releasing amounts of hydrophobic drugs effective for a range of clinical applications, including inducing and maintaining anesthesia in patients. In certain embodiments, emulsion-based formulations are provided that are capable of supporting controlled release, for example, over a range of rates useful for clinical applications including rapid and sustained release.
    Type: Grant
    Filed: April 24, 2015
    Date of Patent: October 1, 2019
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Sandro Mecozzi, Robert A. Pearce